SAGYX | VTSMX | SAGYX / VTSMX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 29 years | 33 years | - |
Gain YTD | 3.391 | 26.352 | 13% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 3000 | 33,333% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 4.64B | 1.84T | 0% |
Annual Yield % from dividends | 0.30 | 1.26 | 23% |
Returns for 1 year | 4.08 | 26.90 | 15% |
Returns for 3 years | -20.17 | 27.88 | -72% |
Returns for 5 years | -29.19 | 84.16 | -35% |
Returns for 10 years | -36.66 | 192.04 | -19% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
LYFAX | 12.84 | 0.03 | +0.23% |
AlphaCentric Life Sciences & Hlthcare A | |||
FRLAX | 19.22 | -0.07 | -0.36% |
Franklin Real Estate Securities Adv | |||
PIIMX | 26.25 | -0.17 | -0.64% |
Principal Glb Emerging Markets R6 | |||
EAASX | 35.92 | -0.38 | -1.05% |
Eaton Vance Atlanta Capital SMID-Cap A | |||
BSMKX | 17.51 | -0.20 | -1.13% |
iShares Russell Small/Mid-Cap Idx K |